Ignite Creation Date:
2024-07-17 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499688
Status:
COMPLETED
Last Update Posted:
2024-07-12
First Post:
2024-07-07
Brief Title:
A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
Sponsor:
Chongqing Claruvis Pharmaceutical Co Ltd
Organization:
Chongqing Claruvis Pharmaceutical Co Ltd
Organization Data
Organization:
Chongqing Claruvis Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
YY001-001-Ⅲ-REFINE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chongqing Claruvis Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None